137 related articles for article (PubMed ID: 31375598)
21. Clinicopathological aspects of primary hepatocellular carcinoma occurring in patients with liver cirrhosis.
Iwamura K
Tokai J Exp Clin Med; 1982 Sep; 7(5):589-605. PubMed ID: 6190271
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation.
Emile JF; Adam R; Sebagh M; Marchadier E; Falissard B; Dussaix E; Bismuth H; Reynès M
Histopathology; 2000 Dec; 37(6):523-9. PubMed ID: 11122434
[TBL] [Abstract][Full Text] [Related]
23. Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinoma.
Emile JF; Lemoine A; Azoulay D; Debuire B; Bismuth H; Reynès M
Histopathology; 2001 Mar; 38(3):225-31. PubMed ID: 11260303
[TBL] [Abstract][Full Text] [Related]
24. Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma.
Soresi M; Cervello M; Lipani G; Carroccio A; Cartabellotta A; Marasà L; Casto C; Virruso L; Montalto G
Eur J Gastroenterol Hepatol; 1997 Aug; 9(8):805-9. PubMed ID: 9282280
[TBL] [Abstract][Full Text] [Related]
25. The incidence of carcinoma of the prostate in cirrhosis of the liver.
JOHNS VJ; HIRST A
Calif Med; 1950 Dec; 73(6):503-4. PubMed ID: 14792342
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma in patients without cirrhosis in Italy.
Giannini EG; Marenco S; Bruzzone L; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F
Dig Liver Dis; 2013 Feb; 45(2):164-9. PubMed ID: 23047000
[TBL] [Abstract][Full Text] [Related]
27. Histological and genetic heterogeneity in synchronous hepatocellular carcinoma.
Cetta F; Zuckermann M; del Vecchio MT; Ercolani G; Mazziotti A
Gut; 2001 Jul; 49(1):155-6. PubMed ID: 11444236
[No Abstract] [Full Text] [Related]
28. Human livers with cirrhosis and hepatocellular carcinoma have less mitochondrial DNA deletion than normal human livers.
Kotake K; Nonami T; Kurokawa T; Nakao A; Murakami T; Shimomura Y
Life Sci; 1999; 64(19):1785-91. PubMed ID: 10353633
[TBL] [Abstract][Full Text] [Related]
29. Genomic and immunophenotypical differences between hepatocellular carcinoma with and without cirrhosis.
Tretiakova MS; Shabani-Rad MT; Guggisberg K; Hart J; Anders RA; Gao ZH
Histopathology; 2010 May; 56(6):683-93. PubMed ID: 20546333
[TBL] [Abstract][Full Text] [Related]
30. [Liver transplantation for hepatocellular carcinoma. Mid-term results].
Gugenheim J; Crafa F; Fabiani P; Saint-Paul MC; Goubaux B; Ouzan D; Mouiel J
Presse Med; 1992 Nov; 21(39):1846-8. PubMed ID: 1337383
[TBL] [Abstract][Full Text] [Related]
31. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
[TBL] [Abstract][Full Text] [Related]
32. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis.
Blumberg RS; Chopra S; Ibrahim R; Crawford J; Farraye FA; Zeldis JB; Berman MD
Gastroenterology; 1988 Nov; 95(5):1399-402. PubMed ID: 2844622
[TBL] [Abstract][Full Text] [Related]
33. [Surgical resection of hepatocellular carcinoma. Retrospective study of 42 cases].
Huguet C; Nordlinger B; Vacher B; Parc R; Hakami F; Loygue J
Gastroenterol Clin Biol; 1985 Mar; 9(3):244-9. PubMed ID: 2989066
[TBL] [Abstract][Full Text] [Related]
34. [Hepatocellular carcinoma surveillance].
Costentin C
Presse Med; 2017 Apr; 46(4):381-385. PubMed ID: 28081946
[TBL] [Abstract][Full Text] [Related]
35. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
[TBL] [Abstract][Full Text] [Related]
36. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
Mun BS; Ahn HS; Ahn DS; Lee SO
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
[TBL] [Abstract][Full Text] [Related]
37. A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels.
Nakayama A; Fukuda H; Ebara M; Hamasaki H; Nakajima K; Sakurai H
Biol Pharm Bull; 2002 Apr; 25(4):426-31. PubMed ID: 11995918
[TBL] [Abstract][Full Text] [Related]
38. Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Cervello M; Virruso L; Lipani G; Giannitrapani L; Soresi M; Carroccio A; Gambino R; Sanfililippo R; Marasà L; Montalto G
J Cancer Res Clin Oncol; 2000 Jun; 126(6):345-51. PubMed ID: 10870645
[TBL] [Abstract][Full Text] [Related]
39. Hepatic arterial blood flow in large hepatocellular carcinoma with or without portal vein thrombosis: assessment by transcutaneous duplex Doppler sonography.
Săftoiu A; Ciurea T; Gorunescu F
Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):167-76. PubMed ID: 11981341
[TBL] [Abstract][Full Text] [Related]
40. Severity of liver cirrhosis: a key role in the selection of surgical modality for Child-Pugh A hepatocellular carcinoma.
Zhang EL; Liang BY; Chen XP; Huang ZY
World J Surg Oncol; 2015 Apr; 13():148. PubMed ID: 25879526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
